Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02982837
What this trial is testing

To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B

Who this might be right for
Hepatitis B
King Abdullah International Medical Research Center 214
Testing effectiveness (Phase 2)Study completedNCT01194037
What this trial is testing

A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C

Who this might be right for
Chronic Hepatitis C InfectionGenotype 1
HanAll BioPharma Co., Ltd. 30
Not applicableStudy completedNCT01112345
What this trial is testing

An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 133
Post-approval studies (Phase 4)Study completedNCT00357045
What this trial is testing

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Who this might be right for
Major Depression
Portland VA Medical Center
Large-scale testing (Phase 3)Study completedNCT00323804
What this trial is testing

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

Who this might be right for
Hepatitis C, ChronicLiver Fibrosis
ANRS, Emerging Infectious Diseases 372
Testing effectiveness (Phase 2)Study completedNCT00059358
What this trial is testing

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 16
Testing effectiveness (Phase 2)Study completedNCT02363452
What this trial is testing

Reverse Transcriptase Inhibitors in AGS

Who this might be right for
Aicardi-Goutières Syndrome (AGS)
Assistance Publique - Hôpitaux de Paris 11
Large-scale testing (Phase 3)UnknownNCT05182515
What this trial is testing

Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies

Who this might be right for
COVID-19
Centre Hospitalier St Anne 50
Early research (Phase 1)Ended earlyNCT02948426
What this trial is testing

Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT01162785
What this trial is testing

1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 7
Post-approval studies (Phase 4)Study completedNCT00132210
What this trial is testing

Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients

Who this might be right for
Hepatitis CHIV Infections
University Hospital, Bonn 200
Testing effectiveness (Phase 2)Study completedNCT00019474
What this trial is testing

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more
Montefiore Medical Center 60
Post-approval studies (Phase 4)Study completedNCT00502970
What this trial is testing

Short Course of Interferon Treatment in Patients With HCV Infection

Who this might be right for
Hepatitis CChronic DiseaseTreatment
Aga Khan University 150
Testing effectiveness (Phase 2)Study completedNCT01439373
What this trial is testing

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 16
Not applicableStudy completedNCT01007396
What this trial is testing

Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay

Who this might be right for
Latent Tuberculosis Infection
Samsung Medical Center 322
Large-scale testing (Phase 3)Study completedNCT00055874
What this trial is testing

Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Heidelberg University 1,551
Testing effectiveness (Phase 2)Ended earlyNCT04449380
What this trial is testing

Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients

Who this might be right for
COVID-19 Virus Infection
Emanuele Bosi 56
Testing effectiveness (Phase 2)Study completedNCT04980482
What this trial is testing

Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis b
Arbutus Biopharma Corporation 43
Testing effectiveness (Phase 2)Study completedNCT02690103
What this trial is testing

Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV

Who this might be right for
Hepatitis C, Chronic
Cairo University 37
Testing effectiveness (Phase 2)Study completedNCT00078442
What this trial is testing

Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Next Page